Literature DB >> 35131527

Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.

Nicholas P Marotta1, Virginia M-Y Lee2.   

Abstract

Parkinson's disease is a progressive neurodegenerative disorder that is characterized by pathological protein inclusions that form in the brains of patients, leading to neuron loss and the observed clinical symptoms. These inclusions, containing aggregates of the protein α-Synuclein, spread throughout the brain as the disease progresses. This spreading follows patterns that inform our understanding of the disease. One way to further our understanding of disease progression is to model the discrete steps from when a cell first encounters an aggregate to when those aggregates propagate to new cells. This review will serve to highlight the recent progress made in the effort to better understand the mechanistic steps that determine how this propagation happens at the cellular level.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35131527      PMCID: PMC9235864          DOI: 10.1016/j.conb.2022.01.003

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   7.070


  55 in total

1.  Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.

Authors:  P J McLean; H Kawamata; B T Hyman
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

3.  Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Tapan P Patel; Selcuk A Tanik; Dawn M Riddle; Anna Stieber; David F Meaney; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

4.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes.

Authors:  Saïda Abounit; Luc Bousset; Frida Loria; Seng Zhu; Fabrice de Chaumont; Laura Pieri; Jean-Christophe Olivo-Marin; Ronald Melki; Chiara Zurzolo
Journal:  EMBO J       Date:  2016-08-22       Impact factor: 11.598

Review 6.  Clinical overview of the synucleinopathies.

Authors:  Maria J Martí; Eduardo Tolosa; Jaume Campdelacreu
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

7.  C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.

Authors:  Ryan P McGlinchey; Shannon M Lacy; Katherine E Huffer; Nahid Tayebi; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

8.  Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.

Authors:  Jichao Sun; Lina Wang; Huan Bao; Sanjay Premi; Utpal Das; Edwin R Chapman; Subhojit Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

9.  Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network.

Authors:  Simona Gribaudo; Philippe Tixador; Luc Bousset; Alexis Fenyi; Patricia Lino; Ronald Melki; Jean-Michel Peyrin; Anselme L Perrier
Journal:  Stem Cell Reports       Date:  2019-01-10       Impact factor: 7.765

Review 10.  Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.

Authors:  Francesca Longhena; Gaia Faustini; Maria Grazia Spillantini; Arianna Bellucci
Journal:  Int J Mol Sci       Date:  2019-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.